Brainstorm Cell Therapeutics Inc. (BCLI) |
|---|
| $2.06 52 Week Low | $4.13 2017-04-28 14:16:52 MDT | $5.1 52 Week High |
| Healthcare Sector | Biotechnology Industry |
| Nasdaq Stock Exchange | United States Country |
| Market Cap: | $76,990,000 | Micro Cap (Less than $200M) |
| Analyst Recommendation: | 2 | Analysts say: Buy. (1=Strong Buy, 5=Strong Sell) |
| Beta: | 2.28 | Higher Volatility Stock (beta over 1). Stock will go up more when the market goes up, and go down more when the market goes down. Beta of 1 means stock would match the S&P 500 Index. |
ForwardPE: Unknown | 5 Yr Est Growth: Unknown | Yield: 0.00% |
PEG-Y Ratio: N/A | Unknown PEG-Y ratio |
% Above 50 DayMA: 1.98% | % Above 200 DayMA: 37.21% |
BCLI Performance 52 Weeks: 85.45% | S&P 500 Performance 52 Weeks: 13.50% |
Uptrend is still intact: BCLI is above both 50 and 200 day Moving Averages. There is hope because 50 Day MA is still above 200 Day MA. Stock is closer to 52 Week High than 52 Week Low. | BCLI outperforming S&P 500 by 71.95% the last 52 Weeks. |
Price To Book: 7.7 | OK Value. Low Price to Book means better value. A P/B value of 5 or less is great. |
EV to EBITDA: -13.24 | Unknown EV to EBITDA ratio |
| Field | Value | Average | Comments |
|---|---|---|---|
| % Held By Insiders | 15.19% | 17.28% | Held by fewer than average Insiders. |
| % Held By Institutions | 9.70% | 62.07% | Institutional percentage lower than average. Institutions may not have conviction in stock. Or is this a chance for institutions to invest more and boost price? |
| Short % Of Float | 5.47% | 07.02% | Shorted percentage less than average percent. Is stock loved? Do traders and investors believe in the stock? |
| Debt to Equity | N/A | 1.08 | Unknown. |
| Profit Margin % | N/A | -00.18% | Unknown. |
| Operating Margin % | N/A | -05.28% | Unknown. |
| Return on Equity % | -41.47% | -08.79% | Return on Equity less than average percent. Stock can do better than this? |
| Return on Assets % | -22.82% | -01.29% | Return on Assets less than average percent. Stock can do better than this? |
| Revenue Per Employee | $N/A | $883,096.70 | Unknown. |
| Price to Cash | 7.65 | 5.52 | Higher than average Price to Cash. Meaning that the company has a lower percentage of cash as a percent of price. Cash can be good to cushion company during hard times, and as a potential source for buyouts or investments. However, some activists want the cash to be used by a company to buy its own stock, or to increase their dividend, or to invest the money. |
| CPEGY Ratio | N/A | 2.26 | Unknown. |
PROS:
| CONS:
|